Bausch Health Companies Inc.·4

Feb 27, 5:17 PM ET

Charhon Jean-Jacques 4

Research Summary

AI-generated summary

Updated

Bausch Health (BHC) EVP/CFO Charhon Jean-Jacques Receives RSU Award

What Happened
Charhon Jean-Jacques, EVP and Chief Financial Officer of Bausch Health Companies Inc., received an award of 276,055 restricted share units (RSUs) reported on 2026-02-25 (transaction code A). The filing also shows 35,977 common shares were withheld on 2026-02-26 to satisfy tax withholding obligations (transaction code F) at $6.04 per share, totaling $217,301. The grant is reported at $0.00 on the Form 4 because it is an awarded RSU grant rather than a purchase.

Key Details

  • Grant date: 2026-02-25 — 276,055 RSUs awarded (code A).
  • Withholding date: 2026-02-26 — 35,977 shares withheld at $6.04/share for taxes (code F), value $217,301.
  • Vesting: RSUs vest one-third on each of the first three anniversaries after the grant date and are settled in common shares upon vesting (footnote F1).
  • Withholding: The withheld shares satisfy tax obligations related to the RSUs (footnote F2); this is a tax withholding, not an open-market sale.
  • Filing: Form 4 filed 2026-02-27 for activity dated 2026-02-25–02-26. No late filing is indicated in the provided data.
  • Shares owned after the transactions: Not specified in the provided filing details.

Context: RSU awards are compensation that convert to shares as they vest; withholding to cover taxes is routine and does not necessarily indicate a vote of confidence or lack thereof in the company. This report documents an equity award and related tax withholding rather than a discretionary open‑market buy or sell.